Gliclazide vs Metformin hydrochloride/rosiglitazone
National NHS prescribing compared (Prescription Cost Analysis)
Gliclazide was dispensed 488,027.0× as often as Metformin hydrochloride/rosiglitazone in March 2026 — 488,027 items versus 1 in England.
488,027items
Gliclazide · March 2026
NHSBSA Prescription Cost Analysis
1items
Metformin hydrochloride/rosiglitazone · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Gliclazide versus Metformin hydrochloride/rosiglitazone: national items dispensed by month
▬ Gliclazide · ╌ Metformin hydrochloride/rosiglitazone
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Gliclazide | Metformin hydrochloride/rosiglitazone |
|---|---|---|
| Items, March 2026 | 488,027 | 1 |
| Items, last 12 months | 5,853,611 | 7 |
| Net ingredient cost, March 2026 | £924,868 | £4 |
See the full profile for Gliclazide or Metformin hydrochloride/rosiglitazone.